cannabinoids
cannabinoids · page 2
- Policy & Regulation
Report calls for UK Government to turbocharge cannabinoid innovation
A new report has set out recommendations for the UK to become the global leader in cannabinoid innovation.
- CBD Market
Two-city outdoor CBG marketing campaign launched by Cellular Goods
Cellular Goods is running the outdoor digital campaign for the next two months.
- Pharmaceutical
Major shareholder appeals for urgent change at Oxford Cannabinoid Technologies
The appeal states there is an urgent need to address serious governance and sclerotic management issues.
- Pharmaceutical
Positive results for cannabinoid targeting multi-billion pain market
Oxford Cannabinoid Technologies has stated it will begin Phase I clinical trials early next year.
- Companies
Cellular Goods launches UK’s first CBG face serum
CBG has anti-inflammatory and antioxidant properties.
- Cultivation
Proposal for medical cannabis facility put forward on Isle of Man
A public consultation has now been launched on the science innovation and research centre that will be established by Peel NRE.
- Pharmaceutical
Pfizer enters medical cannabis market with new acquisition
Pharma titan Pfizer is to acquire Arena Pharmaceuticals which has a pipeline in cannabinoid therapeutics.
- Adult-Use
Looking back on the cannabis industry in 2021
2021 has been a good year for the cannabis industry, says the new Brightfield Group report.
- Pharmaceutical
Global cannabinoid pharmaceuticals market to reach £1.53bn by 2025
The global cannabinoid pharmaceuticals market has been projected to reach £1.53bn (€1.8bn).
- Cultivation
Cannabinoids supplier expands operations into Europe
American cannabinoid manufacturer and supplier is expanding to supply the European market.
- Data & Analysis
Piauhy Labs to open cannabis research centre in Portugal
Piauhy Labs will study the efficacy of cannabinoids for the treatment of diseases such as autism, epilepsy and Alzheimer’s.
- Companies
Life sciences company to expand into medical cannabis market
Broughton will be focusing on accelerating products to market within strategic markets including the cannabinoids industry.
